Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.10 USD
Change Today -0.10 / -2.38%
Volume 27.6K
CERU On Other Exchanges
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Oliver Steffen Fetzer Ph.D., MBA

Former Chief Executive Officer, President and Director, Cerulean Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Oliver Steffen Fetzer, Ph.D., MBA, has been the Chief Executive Officer of Synthetic Genomics, Inc. since October 27, 2014. Dr. Fetzer served as the Chief Executive Officer and President of Cerulean Pharma Inc. from April 8, 2009 to October 29, 2014. Dr. Fetzer served as a Senior Vice President of Corporate Development and Research & Development at TerraGen Discovery, Inc. from July 2004 to September 2007. From January 2003 to July 2004, Dr. Fetzer served as a Senior ...

Read Full Background

Corporate Headquarters*

840 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-551-9600
Fax: 617-494-1544

Board Members Memberships*

Director, Chairman of Compensation Committee and Member of Nomination & Governance Committee
Chief Executive Officer and Director


Carnegie Mellon University
Medical University of South Carolina
College of Charleston

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CERU:US $4.10 USD -0.10


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERULEAN PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at